Depression Rating Scales in the Elderly

Depression Rating Scales in the Elderly A. 20 High-Yield Points Which Scale, and When

A fundamental distinction must open the answer: - Screening scales (detect possible cases) — GDS, CES-D, PHQ-2 and PHQ-9 - Severity and monitoring scales (measure change once diagnosed) — MADRS (preferred), HDRS - Special-population scale (severe cognitive impairment) — Cornell Scale for Depression in Dementia (CSDD)

Diagnosis is clinical. Formal diagnostic interviews such as the Composite International Diagnostic Interview (CIDI), aimed at establishing a DSM diagnosis, are very time-consuming and require extensive training — so the diagnosis is usually made clinically, with or without a screening instrument.

Screening in primary care is critical — not only because depression is frequent, but because suicidal ideation can be detected by screening.

The key cognitive threshold: in severe cognitive impairment (MMSE below 18), the GDS and CES-D become less reliable, and the Cornell Scale for Depression in Dementia is advised instead.

Monitoring rule: once depression is diagnosed, severity must be evaluated with a depression scale before starting treatment and at least every three months during treatment, and at least every three months for every older person started on any antidepressant treatment — drug or non-drug.

MADRS is the preferred severity scale (Montgomery and Asberg, 1979) because it was designed to be sensitive to change.

The Hamilton Depression Rating Scale (HDRS, 1960) is widely used but has a specific geriatric flaw: it contains relatively many somatic items, so somatic comorbidity can cause over-reporting of depression severity.

This flaw has distorted the literature. The frequently repeated claim that late-life depression presents more somatically rests on a meta-analysis based on studies using the HDRS — so it is unclear how much of the "somatic presentation" is really an artefact of comorbid physical disease inflating somatic items. This is a first-class critical-appraisal point.

Always accompany a depression scale with a cognitive scale — objectify cognition with the MMSE (Folstein) or MoCA (Nasreddine) whenever depression is assessed in an older person.

Depression: - Screening tool: PHQ-2 - Assessment tools: PHQ-9, GDS-15 and GDS-30, SLU AMSAD (Saint Louis University AM SAD), CSDD

The rest of the recommended primary-care set, often asked as a whole: - Delirium: Confusion Assessment Method (CAM) - Dementia screening: AD8, Mini-Cog · Dementia assessment: SLUMS, MMSE, MoCA - Alcohol: CAGE (screen), then SMAST-G (Short Michigan Alcohol Screening Test – Geriatric version) - Agitation in dementia: Cohen-Mansfield Agitation Inventory – short form Where the Scales Sit in Geriatric Assessment

In the CGA framework, the mental health and affective dimension is measured by the Geriatric Depression Scale (Yesavage) and the Zung Self-Rating Depression Scale. Both are in wide use, and shorter screening versions are available without significant loss of accuracy.

A depression screen is one of only two mandatory screens in any older person with functional disability — the other being cognitive screening.

RCP/BGS endorsed scales for rehabilitation: depression is measured by the Geriatric Depression Scale — 30 items, with a 15-item short form. The Philadelphia Geriatric Center Morale Scale measures subjective morale, which is distinct from depression though with some overlap.

Disease-specific scales: - Dementia → Cornell Scale for Depression in Dementia (Alexopoulos, 1988) - Stroke → Stroke Aphasic Depression Questionnaire, Signs of Depression Scale, Visual Analogue Mood Scale - Primary care → PRIME-MD (5 questions mapping to DSM categories)

The GDS family is available as 30-item, 15-item, 5-item and 2-item versions. The 2-item version is used for preliminary screening, followed by a longer version if positive.

PHQ-2 detail: asks how often over the last 2 weeks the person has had (1) little interest or pleasure in doing things and (2) feeling down, depressed or hopeless. Responses: not at all / several days / more than half the days / nearly every day. Score 0–6; 3 or more indicates depression.

Before attributing symptoms to depression, exclude physical illness. Because of symptom overlap and the close association of depression with medical conditions, older patients presenting with apparent depression need careful physical evaluation — this also builds trust with the patient and family.

Baseline investigations in a depressed older patient: complete blood count, ESR, serum electrolytes (sodium mEq/L), glucose and calcium (mg/dL), renal and liver function, thyroid function, vitamin D, vitamin B12 or methylmalonic acid, folate, syphilis serology, urinalysis.

Risk factors to elicit alongside the score: female sex, previous depression, chronic physical illness and ADL limitations, cognitive disorders, personality problems, loss of partner, lack or loss of social contacts, subjective loneliness, recent life events, genetic factors, and drugs commonly used by older people that can cause mood disorder.

USPSTF 2023 — the headline guideline change. Clinicians should screen all adults, including those 65 and older, for major depressive disorder (Grade B), and screen adults aged 19–64 for anxiety disorders. Critically, the USPSTF concluded there was insufficient evidence to recommend for or against screening for anxiety disorders in adults 65 years or older, or for suicide risk in any adult. The tools specifically examined were the PHQ (any version), CES-D, EPDS for perinatal persons, and the GDS for older adults. This replaces the 2016 depression and 2014 suicide-risk statements.

The paradox to quote: depression screening in the elderly is now a Grade B recommendation, but suicide-risk screening remains Grade I (insufficient evidence) — despite older men having the highest suicide rates of any group. The PHQ-9 includes a question assessing suicidal thoughts, so many patients still receive de facto suicide-risk screening.

GDS-15 remains the geriatric standard, with an updated cut-off debate. At the recommended cut-off of 5 or more, pooled sensitivity 0.89 and specificity 0.77. An updated 2000–2019 review found pooled sensitivity 0.80, specificity 0.79, AUC 0.89 — and flagged that diagnostic accuracy is lower in older adults with cognitive impairment. A head-to-head study against structured clinical interview found AUC 0.97 for GDS-15 versus 0.95 for PHQ-9, with GDS-15 of 6 or more giving sensitivity 94% and specificity 88%, while the standard PHQ-9 cut-off of 10 or more was too high for older people (specificity 95% but sensitivity only 71%).

Practical implication: the conventional GDS-15 cut-off of 5 or more misses very few cases of major depression but performs less well for minor depression; some validation work in the very old supports 6 or more. For the PHQ-9, the standard adult cut-off of 10 may be too high in older adults — consider a lower threshold.

Ultra-short versions are now meta-analytically validated. GDS-4 and GDS-5 were assessed across 23 studies (5,048 participants): at cut-off 2, GDS-5 sensitivity 0.85, specificity 0.75; GDS-4 sensitivity 0.77, specificity 0.75. These are the appropriate choices for resource-limited and high-volume Indian settings.

Screening is now embedded in structural frameworks: - German S3 CGA guideline (2024): "affect" is one of the six mandatory CGA core dimensions. - WHO ICOPE: psychological well-being is one of the six intrinsic-capacity domains screened, with PHQ-9 as the step-2 tool. - ASCO 2023 Practical Geriatric Assessment: includes a psychological and depression domain for every cancer patient aged 65 and above. - Age-Friendly 4Ms: depression falls under Mentation, alongside dementia and delirium.

Indian context. LASI wave-1 found major depressive disorder in 8.2% of adults aged 60 and above. Depression is also the critical multiplier of disability: the combination of hypertension plus arthritis plus high depressive symptoms was associated with greater ADL–IADL disability than any other multimorbidity combination, with population attributable fractions of about 22–24%. In practice, screening for depression is itself a disability-prevention intervention.